Watch Dr. Sylvia Boj discussing how HUB Organoids accelerate the development of new therapeutics for inflammatory diseases.
The lack of preclinical cellular models that recapitulate the human disease is a major setback in the study of non-oncogenic conditions with an inflammatory component.
